Assignee
PH PHARMA CO LTD
KR·6 granted patents·4 pending applications·1 citations·filing 2016–2020
Top patents by PatentIndex Score
10 records- 0169US10316001B2Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrilePH PHARMA CO LTD·Filed 2016·Granted Jun 11, 2019·1 cites·18 claims
- 0268US10815246B2Thailanstatin analogsPH PHARMA CO LTD·Filed 2019·Granted Oct 27, 2020·0 cites·17 claims
- 0366US11691982B2Thailanstatin analogsPH PHARMA CO LTD·Filed 2020·Granted Jul 4, 2023·0 cites·9 claims
- 0466US10806735B2Use of neutrophil elastase inhibitors in liver diseasePH PHARMA CO LTD·Filed 2019·Granted Oct 20, 2020·0 cites·4 claims
- 0563US10676443B2Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrilePH PHARMA CO LTD·Filed 2019·Granted Jun 9, 2020·0 cites·7 claims
- 0658US2021069192A1Use of neutrophil elastase inhibitors in liver diseasePH PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0757US10301319B2Thailanstatin analogsPH PHARMA CO LTD·Filed 2018·Granted May 28, 2019·0 cites·4 claims
- 0848US2022296597A1Use of a neutrophil elastase inhibitor in lung diseasePH PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0946US2021113563A14-(4-cyano-2-thioaryl)dihydropyrimidinones for treating chronic woundsPH PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1035US2019008867A14-(4-cyano-2-thioaryl)dihydropyrimidinones for treating chronic woundsPH PHARMA CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PH PHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →